Omega Diagnostics : Closure of Omega Diagnostics GmbH

Regulatory Story

Go to market news section

Omega Diagnostics Group PLC - ODX Closure of Omega Diagnostics GmbH Released 07:41 02-May-2018

RNS Number : 8614M

Omega Diagnostics Group PLC 02 May 2018

Omega Diagnos�cs Group PLC ("Omega" or "the Company" or the "Group")

Closure of Omega Diagnos�cs GmbH

Omega (AIM: ODX), the medical diagnos�cs company focused on allergy, food intolerance and infec�ous disease, announces the closure of Omega Diagnos�cs GmbH ("Omega GmbH").

Further to the announcement on 10 April 2018, the Board has not been able to conclude any transac�on for a sale of Omega GmbH. The Board has therefore decided to ini�ate insolvency proceedings through the German court system, as soon as prac�cally possible, under the guidance of its legal advisers. The con�ngent cost associated with this closure is not expected to be more than £0.45m and could be significantly less than this figure.

For the year ended 31 March 2018, Omega GmbH had sales of approximately €3.2 million* and incurred an EBITDA loss of approximately €0.4 million*.

The informa�on communicated in this announcement is inside informa�on for the purposes of Ar�cle 7 of EU Regula�on 596/2014.

* Figures for the year ended 31 March 2018 are unaudited as at the date of this release.

Contacts:

Omega Diagnos�cs Group PLC	Tel: [phone]
Colin King, Chief Execu�ve	www.omegadiagnos�cs.com
Kieron Harbinson, Group Finance Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate

Finance)

Camille Gochez/ Abigail Wayne (Corporate Broking)

Walbrook PR Limited

Tel: [phone] [e-mail]

Paul McManus Lianne Cawthorne

Mob: [phone] Mob: [phone]

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCSSUSMEFASEDI

CLOSE

London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries.Terms and conditions, including restrictions on use and distribution apply.

©2014 London Stock Exchange plc. All rights reserved

Closure of Omega Diagnostics GmbH - RNS